CEO Miles White

CEO Miles White

CEO Miles White has been the chief executive officer of Abbott Laboratories since 1999. He is 51 years old. Follow Mr. White and Abbott Laboratories in the news and blogs or share your own opinion about the company and its leadership.

RSS
Articles
Sorted by: Top Picks
+ write article

RETAIL SALES REPRESENTATIVE - Des Moines at Abbott Laboratories (Iowa)

Written by anak2 on
Retail Sales Representative Job Description The Retail Sales Representative is responsible for servicing and selling to retail accounts within an assigned territory with the objective to increase sales volume for the Retailer as well as… Go here to read the rest: Related Content Subscribe to the post comments feeds or Leave a trackback Read Full Story

FINANCIAL ANALYST at Abbott Laboratories (Princeton, NJ)

Written by anak2 on
Responsible for supporting financial reporting and consolidation functions for the Abbott Point of Care division, including the development of accurate and timely financial statements in accordance with GAAP and corporate policy, as well… Read Full Story

Sr. Financial Analyst at Abbott Laboratories (Illinois)

Written by anak2 on
The Sr Financial Analyst in Abbott Diagnostics Division (ADD) US Commercial Operations is responsible for supporting the Blood Screening & Reference Lab business units through financial reporting and analysis. This position provides direct… Read Full Story

SR. IT AUDITOR II at Abbott Laboratories (Illinois)

Written by anak2 on
Conduct global information technology and operations audits & formulate recommendations for improvement in operating performance & controls. Primary areas of focus include detailed reviews of ERP systems, financial systems, supporting… Read Full Story

LOGISTICS SUPERVISOR at Abbott Laboratories (Altavista, VA)

Written by anak2 on
Primary Function / Primary Goals / Objectives: The Logistics Supervisor is responsible for the effective utilization of manpower, storage space and equipment resources; proper administration of control policies; providing effective high… Read Full Story
more »
Business Photos
Sorted by: Top Rated
+ add picture
No pictures yet.
more »
News
/ edit news
Zacks Analyst Blog Highlights: Citibank, KeyCorp, Ford, Abbott Laboratories...
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Citibank (NYSE: C), KeyCorp (NYSE: KEY), Ford (NYSE: F), Abbott Laboratories Inc. (NYSE: ABT) and Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA). Get the most recent insight from...  
From businesswire.com ()
More perspectives...
UPDATE 1-US group asks FDA to ban Abbott diet drug
Consumer AffairsUPDATE 1-US group asks FDA to ban Abbott diet drugReutersWASHINGTON, Dec 3 (Reuters) - Abbott Laboratories Inc's (ABT.N) weight-loss drug Meridia should be banned immediately because of ...US Should Ban Diet Drug Meridia, Consumer Group SaysAttorney at LawAbbott's diet pill should be banned: groupCrain's Chicago Businessall 157 news articles »  
From news.google.com ()
Related news:
More perspectives...
Abbott settles one of four Tricor patent suits
(Reuters) — Abbott Laboratories Inc. said on Monday it settled U.S. patent litigation with Teva Pharmaceutical Industries Ltd. over Abbott 's blockbuster triglycerides drug Tricor. The settlement involves the 145 milligram dose of Tricor, which makes up the large majority of Tricor's sales. ...  
From chicagobusiness.com ()
More perspectives...
Abbott gives Teva TriCor rights as early as 2011
NEW YORK - Pharmaceutical and medical products maker Abbott Laboratories and Laboratories Fournier SA granted intellectual property rights for the cholesterol medication TriCor to Teva Pharmaceutical Laboratories Ltd., according to a Securities and ...  
From msnbc.msn.com ()
More perspectives...
Abbott, Teva Reach Deal That Delays Sales of Generic TriCor
Abbott Laboratories said it reached a deal with Teva Pharmaceuticals that postpones the sale of a generic version of its blockbuster cholesterol drug TriCor until March 28, 2011, at the earliest.  
From wsjonline.com ()
Related news:
More perspectives...
more »
Sponsors
More From Zimbio
HomeTerms & PoliciesHelpCompany WikizineFor BloggersAdvertiseSitemapAbout Us
Copyright © 2009 - Zimbio, Inc. Some rights reserved.